Clinical Trial Update: NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients. [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating safety, efficacy, and tolerability of rivastigmine patch in patients with mild to moderate Alzheimer's disease has been completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Rivastigmine Patch (Rivastigmine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Mild to Moderate Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-09-12